Back to search

Article

Effects of gabexate mesylate on the gut microbiota and metabolomics in rats with sepsis

2022-05-17

Abstract excerpt

<h4>Background: </h4> Sepsis develops in millions of people worldwide annually. Only 30%–40% of septic shock cases have positive microbial culture results [1] . Currently, there is no clear early diagnostic marker for sepsis. The gut microbiota and metabolomics significantly change in sepsis. Previous studies have reported that gabexate mesylate (GM) could alleviate liver and lung injury and high inflammatory stat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
56daba1e-7670-5d28-a3e7-2fa0568fcc08
DOI
10.21203/rs.3.rs-1630217/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of gabexate mesylate on the gut microbiota and metabolomics in rats with sepsisDOI 10.21203/rs.3.rs-1630217/v1
Select a neighboring publication to make it the new centre.